Response Genetics (RGDXQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2010 | 12-2009 | 09-2009 | 06-2009 | 03-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,090 | 7,050 | 9,290 | 7,040 | 10,160 |
| Receivables | 2,480 | 1,980 | 1,700 | 790 | 850 |
| Other current assets | 460 | 420 | 440 | 400 | 450 |
| TOTAL | $12,030 | $9,450 | $11,430 | $8,230 | $11,460 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 80 | 80 | 60 | 60 | 60 |
| TOTAL | $80 | $80 | $60 | $60 | $60 |
| Total Assets | $13,380 | $10,790 | $12,800 | $9,640 | $12,990 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,000 | 720 | 870 | 920 | 950 |
| Accrued Expenses | 2,190 | 1,420 | 1,460 | 1,770 | 1,970 |
| Other current liabilities | 2,540 | 2,590 | 2,120 | 2,800 | 2,560 |
| TOTAL | $5,740 | $4,750 | $4,450 | $5,500 | $5,480 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 3,970 | 0 | 0 | 0 |
| TOTAL | $1,110 | $5,380 | $2,270 | $390 | $1,600 |
| Total Liabilities | $6,860 | $10,140 | $6,730 | $5,900 | $7,090 |
| Shareholders' Equity | |||||
| Common Shares | 7,970 | 150 | 150 | 120 | 120 |
| Retained earnings | -41,240 | -39,140 | -37,420 | -35,450 | -33,060 |
| Other shareholders' equity | -190 | -180 | -200 | -210 | -260 |
| TOTAL | $6,510 | $680 | $6,070 | $3,740 | $5,900 |
| Total Liabilities And Equity | $13,370 | $10,820 | $12,800 | $9,640 | $12,990 |